Cargando…
Complications, Adverse Drug Events, High Costs, and Disparities in Multisystem Inflammatory Syndrome in Children vs COVID-19
IMPORTANCE: Multisystem inflammatory syndrome in children (MIS-C) causes severe inflammation of multiple organ systems after SARS-CoV-2 infection. During the pandemic, surveillance reporting of MIS-C was voluntary, with likely underreporting. For a rare syndrome like MIS-C, numerous data are needed...
Autores principales: | Encinosa, William, Moon, Kyung, Figueroa, Jessica, Elias, Youssef |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857408/ https://www.ncbi.nlm.nih.gov/pubmed/36602804 http://dx.doi.org/10.1001/jamanetworkopen.2022.44975 |
Ejemplares similares
-
Examination of Adverse Reactions After COVID-19 Vaccination Among Patients With a History of Multisystem Inflammatory Syndrome in Children
por: Elias, Matthew D., et al.
Publicado: (2023) -
Infliximab in patients with psoriasis and other inflammatory
diseases: evaluation of adverse events in the treatment of 168 patients
por: Antonio, João Roberto, et al.
Publicado: (2016) -
Echocardiographic Indicators Associated with Adverse Clinical Course and Cardiac Sequelae in Multisystem Inflammatory Syndrome in Children with Coronavirus Disease 2019
por: Sanil, Yamuna, et al.
Publicado: (2021) -
Racial and Socioeconomic Disparities in Multisystem Inflammatory Syndrome in Children in the United States
por: Ghimire, Laxmi V., et al.
Publicado: (2023) -
MULTISYSTEM INFLAMMATORY SYNDROME IN ADULTS: AN EMERGING COMPLICATION OF COVID-19
por: Abdelhamid, Ahmed, et al.
Publicado: (2022)